Ardelyx Profit Margin

The latest profit margin for ARDX is -13.58% as of March 2026. That compares with -14.86% in the prior-year period — up 8.7% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Ardelyx's historical trend and sector peers before judging valuation or financial health.

Over the past year, ARDX's profit margin moved from -14.86% to -13.58% — a 8.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ardelyx's valuation or profitability profile.

Against Healthcare companies, ARDX currently prints -13.58% for profit margin, while the sector average sits near 15.58%. That is roughly 187.1% below the sector mean. Large gaps often invite a closer look at Ardelyx's growth, margins, and balance sheet.

Profit Margin shows how effectively Ardelyx converts resources into returns. At -13.58%, ARDX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -14.86% in the prior-year period — up 8.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ARDX's profit margin (-13.58%), review year-over-year change from -14.86%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.